logo-loader
viewLeanLife Health

LeanLife Health production equipment due soon as it sets up first facility in North America

The company has also acquired lab and testing equipment, it told investors

testubes
LeanLife has developed a patented process to isolate omega 3 fatty acids

Food additives group LeanLife Health Inc (CVE:LLP) says equipment needed to produce its omega 3 products will be delivered soon, sending shares slightly higher.

The main item is a BioCube processing plant, which, with associated apparatus, is estimated to cost $800,000. So far LeanLife has spent $630,000.

READ - LeanLife Health signs sales agreement with RD Heritage

The company has also acquired lab and testing equipment for essential testing of raw materials and finished product, it said.

Additional equipment is being ordered and will be set up in a new lab.

The firm has leased around 4,000 sq ft of industrial space in South Vancouver, where it will spend an estimated $350,000 on improvements, security systems and initial supplies.

The production capacity of the equipment is estimated as at least 2.5mln litres of product a year, the firm added.

It's a busy period for the firm.

Last week it struck a sales agreement with RD Heritage Group LLC for its omega 3 products.

RD Heritage will market and sell the company's products and assist with marketing strategies.

It will also carry out market analysis to define a global sales strategy and appoint distributors to increase sales opportunities.

LeanLife has developed a patented process to isolate omega 3 fatty acids from flax (linen) seeds.

The products are sold as a food additive to food processors making such items as bread, noodles and milk products.

In Toronto, LeanLife shares gained 3.03% to C$0.34.

Quick facts: LeanLife Health

Price: 0.05 CAD

CSE:LLP
Market: CSE
Market Cap: $4.83 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LeanLife Health named herein, including the promotion by the Company of LeanLife Health in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read